Table 1.

Changes of nutritional, hematological and lipid profile before the start of ND treatment, at, 2, 4 months during the treatment and 2 months after withdrawing treatment in 64 hemodialysis patients.

	Basal (Mean ± SD)	2 months (Mean ± SD)	4 months (Mean ± SD)	ND withdrawal 2 months (Mean ± SD)
Albumin(g/dl)	3.6 ± 0.8	3.9 ± 0.8	4.3 ± 1.0 (p < 0.0001)*	4.0 ± 1.0 (p = 0.001)**
Creatinine(mg/dl)	9.5 ± 3.4	10.7 ± 3.8	11.4 ± 3.4 (p < 0.009)*	10.3 ± 3.4 (p = 0.008)**
Hemoglobin(g/dl)	9.2 ± 2.2	9.9 ± 2.2	10.2 ± 2.1 (p < 0.03)*	9.9 ± 1.8 (p = 0.001)**
Hematocrit (%)	28.2 ± 6.7	30.2 ± 6.6	31.3 ± 6.4 (p < 0.03)*	30.4 ± 5.5 (p = 0.001)**
Cholesterol(mg/dl)	179.4 ± 38.5	196.1 ± 38.8	200.1 ± 39.1 (p = 0.007)*	197.6 ± 35.5 (p < 0.0001)**
HDL-C(mg/dl)	37.5 ± 4.3	36.4 ± 3.7	35.4 ± 3.0 (p = 0.007)*	36.3 ± 3.4 (p = 0.004)**
Triglyceride(mg/dl)	178.7 ± 85.9	180.4 ± 73.3	187.6 ± 70.7 (p < 0.04) ***	181.8 ± 64.6 (p = 0.085)* ***
Lp(a)(mg/dl)	40.6 ± 24.2	33.1 ± 19. 2	31.3 ± 17.2 (p < 0.0001) ***	33.3 ± 21.8 (p < 0.0001)* ***

*, Comparison analysis between base, two and post of treatment values were performed using multiple comparisons by one-way ANOVA. **, Paired t-test was used to assess significancy of differences between base and 2 months after withdrawing treatment. ***, Comparison analysis between base, two and post of treatment values were performed using Friedman test. ****, Wilcoxon signed ranks test was used to assess significancy of differences between the base and 2 months after withdrawing of treatment.